Literature DB >> 34043978

The Multifaceted Effects of Breast Cancer on Tumor-Draining Lymph Nodes.

Samir Jana1, Ronald A Muscarella1, Dennis Jones2.   

Abstract

Breast cancer (BC) accounts for significant morbidity and mortality among women worldwide. About one in three patients with breast cancer present with lymph node (LN) metastasis and LN status is one of the most important prognostic predictors in patients with BC. In addition to their prognostic value, LNs initiate adaptive immunity against BC. Yet, BC cells often avoid immune-mediated destruction in LNs. This review provides an overview of the ways by which BC cells modulate LN stromal and hematopoietic cells to promote metastasis and immune evasion.
Copyright © 2021 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2021        PMID： 34043978      PMCID： PMC8351123          DOI： 10.1016/j.ajpath.2021.05.006

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   5.770


  100 in total

1.  CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer-Draining Lymph Nodes.

Authors:  Alexandra Frazao; Meriem Messaoudene; Nicolas Nunez; Nicolas Dulphy; France Roussin; Christine Sedlik; Laurence Zitvogel; Eliane Piaggio; Antoine Toubert; Anne Caignard
Journal:  Cancer Immunol Res       Date:  2018-12-04       Impact factor: 11.151

2.  Angiogenesis in ductal breast carcinoma. Comparison of microvessel density between primary tumour and lymph node metastasis.

Authors:  P Arapandoni-Dadioti; A Giatromanolaki; H Trihia; A L Harris; M I Koukourakis
Journal:  Cancer Lett       Date:  1999-04-01       Impact factor: 8.679

3.  Preparing the "soil": the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells.

Authors:  Chao-Nan Qian; Bree Berghuis; Galia Tsarfaty; MaryBeth Bruch; Eric J Kort; Jon Ditlev; Ilan Tsarfaty; Eric Hudson; David G Jackson; David Petillo; Jindong Chen; James H Resau; Bin Tean Teh
Journal:  Cancer Res       Date:  2006-10-23       Impact factor: 12.701

4.  The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer.

Authors:  Takuya Shiota; Yuko Miyasato; Koji Ohnishi; Mutsuko Yamamoto-Ibusuki; Yutaka Yamamoto; Hirotaka Iwase; Motohiro Takeya; Yoshihiro Komohara
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

Review 5.  New Insights into Tumor-Infiltrating B Lymphocytes in Breast Cancer: Clinical Impacts and Regulatory Mechanisms.

Authors:  Meng Shen; Jian Wang; Xiubao Ren
Journal:  Front Immunol       Date:  2018-03-08       Impact factor: 7.561

6.  Clinicopathological Evaluation of the Potential Anatomic Pathways of Systemic Metastasis from Primary Breast Cancer Suggests an Orderly Spread Through the Regional Lymph Nodes.

Authors:  S David Nathanson; Shravan Leonard-Murali; Charlotte Burmeister; Laura Susick; Patricia Baker
Journal:  Ann Surg Oncol       Date:  2020-07-27       Impact factor: 5.344

7.  Sentinel lymph node B cells can predict disease-free survival in breast cancer patients.

Authors:  Kim R M Blenman; Ting-Fang He; Paul H Frankel; Nora H Ruel; Erich J Schwartz; David N Krag; Lee K Tan; John H Yim; Joanne E Mortimer; Yuan Yuan; Peter P Lee
Journal:  NPJ Breast Cancer       Date:  2018-08-23

8.  Remodeling of the Lymph Node High Endothelial Venules Reflects Tumor Invasiveness in Breast Cancer and is Associated with Dysregulation of Perivascular Stromal Cells.

Authors:  Tove Bekkhus; Teemu Martikainen; Anna Olofsson; Mathias Franzén Boger; Daniel Vasiliu Bacovia; Fredrik Wärnberg; Maria H Ulvmar
Journal:  Cancers (Basel)       Date:  2021-01-08       Impact factor: 6.639

9.  Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing.

Authors:  Jonas Demeulemeester; Parveen Kumar; Elen K Møller; Silje Nord; David C Wedge; April Peterson; Randi R Mathiesen; Renathe Fjelldal; Masoud Zamani Esteki; Koen Theunis; Elia Fernandez Gallardo; A Jason Grundstad; Elin Borgen; Lars O Baumbusch; Anne-Lise Børresen-Dale; Kevin P White; Vessela N Kristensen; Peter Van Loo; Thierry Voet; Bjørn Naume
Journal:  Genome Biol       Date:  2016-12-09       Impact factor: 13.583

10.  CXCR2+ MDSCs promote breast cancer progression by inducing EMT and activated T cell exhaustion.

Authors:  Ha Zhu; Yan Gu; Yiquan Xue; Ming Yuan; Xuetao Cao; Qiuyan Liu
Journal:  Oncotarget       Date:  2017-12-07
View more
  3 in total

1.  Drug-eluting immune checkpoint blockade antibody-nanoparticle conjugate enhances locoregional and systemic combination cancer immunotherapy through T lymphocyte targeting.

Authors:  David M Francis; Margaret P Manspeaker; Paul A Archer; Lauren F Sestito; Alexander J Heiler; Alex Schudel; Susan N Thomas
Journal:  Biomaterials       Date:  2021-10-13       Impact factor: 12.479

Review 2.  Lymph Nodes as Anti-Tumor Immunotherapeutic Tools: Intranodal-Tumor-Specific Antigen-Pulsed Dendritic Cell Vaccine Immunotherapy.

Authors:  Takashi Morisaki; Takafumi Morisaki; Makoto Kubo; Shinji Morisaki; Yusuke Nakamura; Hideya Onishi
Journal:  Cancers (Basel)       Date:  2022-05-15       Impact factor: 6.575

3.  Alterations in Immune Response Profile of Tumor-Draining Lymph Nodes after High-Intensity Focused Ultrasound Ablation of Breast Cancer Patients.

Authors:  Xue-Qiang Zhu; Pei Lu; Zhong-Lin Xu; Qiang Zhou; Jun Zhang; Zhi-Biao Wang; Feng Wu
Journal:  Cells       Date:  2021-11-29       Impact factor: 6.600
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.